Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C288630-10mg | 10mg | In stock | $64.90 | |
C288630-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $207.90 | |
C288630-250mg | 250mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $936.90 |
Rho/SRF pathway inhibitor; induces intermediate mesoderm differentiation from ESCs
Synonyms | CCG-1423|285986-88-1|CCG1423|CCG 1423|n-(2-(4-chloroanilino)-1-methyl-2-oxoethoxy)-3,5-bis(trifluoromethyl)benzamide|N-((1-((4-chlorophenyl)amino)-1-oxopropan-2-yl)oxy)-3,5-bis(trifluoromethyl)benzamide|N-[1-(4-chloroanilino)-1-oxopropan-2-yl]oxy-3,5-bis( |
---|---|
Specifications & Purity | Moligand™, ≥99%(HPLC) |
Biochemical and Physiological Mechanisms | Rho/SRF pathway inhibitor; stimulates apoptosis of a melanoma cell line overexpressing RhoC (A375M2). Suppresses Rho-dependent invasion of PC-3 prostate cancer cellsin vitroand inhibits lysophosphatidic acid-induced DNA synthesis in PC-3 prostate cancer c |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-[1-(4-chloroanilino)-1-oxopropan-2-yl]oxy-3,5-bis(trifluoromethyl)benzamide |
---|---|
INCHI | InChI=1S/C18H13ClF6N2O3/c1-9(15(28)26-14-4-2-13(19)3-5-14)30-27-16(29)10-6-11(17(20,21)22)8-12(7-10)18(23,24)25/h2-9H,1H3,(H,26,28)(H,27,29) |
InChi Key | DSMXVSGJIDFLKP-UHFFFAOYSA-N |
Canonical SMILES | CC(C(=O)NC1=CC=C(C=C1)Cl)ONC(=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F |
Isomeric SMILES | CC(C(=O)NC1=CC=C(C=C1)Cl)ONC(=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F |
PubChem CID | 2726015 |
Molecular Weight | 454.75 |
PubChem CID | 2726015 |
---|---|
CAS Registry No. | 285986-88-1 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J2119322 | Certificate of Analysis | Aug 09, 2024 | C288630 |
J2119334 | Certificate of Analysis | Aug 09, 2024 | C288630 |
J2119351 | Certificate of Analysis | Aug 09, 2024 | C288630 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 45.48, Max Conc. mM: 100 |
---|---|
Sensitivity | heat sensitive |
1. Evelyn CR, Wade SM, Wang Q, Wu M, Iñiguez-Lluhí JA, Merajver SD, Neubig RR. (2007) CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.. Mol Cancer Ther, 6 (8): (2249-60). [PMID:17699722] |